0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Summary

RATIONALE: Drugs used in chemotherapy, such as pentamidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well pentamidine works in treating patients with relapsed or refractory melanoma.

Timeline

Start

2008-07

Primary completion

2012-08

Completion

2012-11

Outcome

Outcome not reported

Stopped (Enrollment): “Study was closed at the suggestion of DSMB prior to obtaining target enrollment”

Drugs

Indications